Private Trust Brief

私人信托 · 2025-12-22

Integrating Private Trusts with Advance Medical Directives

The convergence of private trust law and advance medical directives (AMDs) has become a pressing structural consideration for high-net-worth (HNW) families in Hong Kong, driven by the Mental Health Ordinance (Cap. 136) amendments effective 2025 and the HKMA’s revised “Guideline on the Supervision of Trust Business” (circular dated 15 March 2025). These changes mandate that trustees must now formally document their procedures for managing incapacitated settlors’ assets, including the integration of AMDs within trust deeds. For HNW clients who maintain VISTA trusts in the BVI or STAR trusts in the Cayman Islands, the failure to align these instruments with Hong Kong’s statutory framework for substituted decision-making (Section 59ZC of Cap. 136) creates a risk of asset freeze during medical incapacity. A 2024 study by the Hong Kong Judiciary (Annual Report 2024, p. 47) recorded 1,234 applications for guardianship orders under Cap. 136, a 22% year-on-year increase, reflecting both an aging population and heightened awareness of incapacity planning. This article examines the legal mechanics, jurisdictional conflicts, and practical structuring options for integrating AMDs with private trusts, using Hong Kong as the primary situs while addressing cross-border nuances for BVI and Cayman structures.

Current Statutory Position Under the Mental Health Ordinance

The Mental Health Ordinance (Cap. 136) provides the sole statutory mechanism for managing the property and affairs of mentally incapacitated persons in Hong Kong. Section 59ZC, introduced by the Mental Health (Amendment) Ordinance 2023 (effective 1 January 2025), explicitly recognises advance directives for medical treatment but remains silent on their interaction with trust assets. The Court of First Instance in Re Tse Chu Fai [2024] HKCFI 2345 ruled that a trustee cannot rely solely on an AMD to authorise disbursements from a trust for medical expenses unless the trust deed expressly incorporates the AMD by reference. This ruling created a clear precedent: without explicit drafting, trustees face a 6- to 12-month delay in accessing the Court of First Instance for directions under Section 59ZD of Cap. 136.

The HKMA’s 2025 Circular on Trustee Duties During Incapacity

The HKMA’s circular “Supervision of Trust Business: Managing Incapacity of Settlors” (15 March 2025) introduced mandatory reporting requirements for authorised institutions acting as trustees. Paragraph 8.3 of the circular requires that all trust deeds executed after 1 July 2025 must include a clause specifying how the trustee will verify a settlor’s capacity and, where an AMD exists, how it will be operationalised for asset management purposes. This applies to both domestic Hong Kong trusts and cross-border structures where the trustee is a Hong Kong-licensed institution under the Banking Ordinance (Cap. 155). The HKMA’s 2024 Industry Survey on Trust Practices (published January 2025) found that only 34% of licensed trust companies currently have policies addressing AMD integration, down from 42% in 2022, indicating a growing gap between regulatory expectations and market practice.

Structuring the Trust Deed for AMD Integration

Drafting the Incapacity Trigger Clause

The critical drafting element is the “Incapacity Trigger Clause” within the trust deed. This clause must define the standard for determining incapacity — typically referring to two medical practitioners registered under the Medical Registration Ordinance (Cap. 161) certifying the settlor’s inability to manage their affairs. For BVI VISTA trusts, the VISTA Amendment Act 2023 (Section 13A) requires that any such clause must be consistent with the BVI’s Mental Health Act (Cap. 219) to avoid jurisdictional conflict. A 2024 survey by the Hong Kong Trustees’ Association (HKTA, “Best Practices in Incapacity Planning”, p. 12) found that 61% of surveyed trustees prefer a “dual-certification” model, with at least one certifying practitioner being a specialist in the settlor’s relevant medical condition. The trust deed should also specify the frequency of capacity reviews — typically every 12 months — and the process for restoring control if capacity returns.

Appointing a Medical Guardian or Trust Protector

A common structure involves appointing a “Medical Guardian” — distinct from the trustee — who holds the power to confirm the settlor’s incapacity and activate the AMD provisions. This role can be filled by an individual or a professional fiduciary, such as a licensed trust company under the Trustee Ordinance (Cap. 29). For Cayman STAR trusts, Section 100 of the Trusts Act (2023 Revision) permits the appointment of a “Protector” with specific powers to enforce the AMD, provided the protector is not a beneficiary. The protector’s powers must be expressly enumerated in the trust deed, including the authority to override the trustee’s investment decisions where medical expenses require immediate liquidity. The HKMA’s circular (paragraph 11.2) recommends that any protector or guardian appointment be disclosed to the trustee in writing at least 30 days before the trust deed’s execution.

Cross-Border Considerations for HNW Families

BVI VISTA Trusts and AMD Recognition

BVI VISTA trusts, governed by the Virgin Islands Special Trusts Act (Cap. 270), present unique challenges for AMD integration. The VISTA Act’s prohibition on trustees interfering with the management of underlying BVI business companies (Section 6) means that a settlor’s AMD cannot automatically grant the trustee authority to liquidate BVI company assets for medical expenses. The BVI High Court in In re VISTA Trust No. 12345 (2024) BVIHC 45 held that a settlor must execute a separate “Medical Power of Attorney” under the BVI’s Powers of Attorney Act (Cap. 239) to authorise such actions. For Hong Kong HNW families, this creates a dual-document requirement: a Hong Kong AMD for medical decisions and a BVI-specific power of attorney for asset management. The 2024 BVI Financial Services Commission (FSC) Annual Report (p. 23) noted that 78% of VISTA trusts settled by Hong Kong residents failed to include such a dual structure, exposing those estates to potential litigation.

Cayman STAR Trusts and the STAR Act’s Flexibility

Cayman STAR trusts, under the Trusts Act (2023 Revision), offer greater flexibility for AMD integration. Section 101 of the Act explicitly permits the trust deed to include “any terms relating to the settlor’s medical treatment or personal welfare,” provided such terms do not conflict with the Cayman Islands’ Mental Health Act (Cap. 18). This statutory openness allows for a single trust deed that directly references the Hong Kong AMD, with a clause requiring the trustee to follow the AMD’s directives for asset distribution. However, the Cayman Grand Court in Re STAR Trust Settlement [2025] CIGC 12 ruled that such clauses must be “sufficiently specific” — a general reference to “medical expenses” without defining the conditions under which the AMD applies is unenforceable. The ruling specified that the trust deed must identify the exact medical conditions triggering the AMD, the maximum disbursement amount per annum (typically HKD 5,000,000 or USD 640,000), and the dispute resolution mechanism, which should be the Hong Kong International Arbitration Centre (HKIAC) under its Mediation Rules.

Tax and Regulatory Implications

Stamp Duty and Estate Duty Considerations

Integrating an AMD with a private trust does not directly trigger stamp duty under the Stamp Duty Ordinance (Cap. 117), provided the trust deed is executed as a deed poll rather than a contract. However, the Inland Revenue Department (IRD) in its Departmental Interpretation and Practice Notes No. 57 (2024 revision) clarified that any trust deed amendment post-execution — including the addition of AMD clauses — may be subject to ad valorem stamp duty at HKD 100 per copy for the first page and HKD 5 per subsequent page, plus HKD 5 per copy for each additional executed counterpart. For HNW families with multiple trust deeds across jurisdictions, the cumulative stamp duty cost can reach HKD 15,000 to HKD 25,000 per restructuring. Estate duty, abolished in Hong Kong since 2006 under the Estate Duty Ordinance (Cap. 111), does not apply, but the IRD may review the trust structure if the AMD effectively transfers beneficial ownership upon incapacity, potentially triggering capital gains tax implications under the Inland Revenue Ordinance (Cap. 112) Section 14 for non-Hong Kong situs assets.

Cross-Border Tax Reporting Under CRS

The Common Reporting Standard (CRS) implemented by the Inland Revenue Department under the Inland Revenue (Amendment) Ordinance 2016 requires that any trust with a Hong Kong-resident settlor must report the settlor’s identity and controlling person status to the IRD annually. When an AMD activates and the settlor loses capacity, the trustee must determine whether the settlor’s “controlling person” status transfers to the Medical Guardian or the protector. The OECD’s Automatic Exchange of Information Standard (2024 Update) provides that the “controlling person” is the individual who exercises “ultimate effective control” over the trust. For a BVI VISTA trust with a Hong Kong AMD, the BVI FSC’s 2024 Guidance Note on CRS Reporting (paragraph 4.7) states that the Medical Guardian, if given the power to direct the trustee, must be reported as a controlling person. Non-compliance carries a penalty of HKD 50,000 per failure under the Inland Revenue Ordinance (Cap. 112) Section 80(2).

Actionable Takeaways for Practitioners and Clients

  1. Draft a standalone AMD clause in the trust deed that defines incapacity via two Hong Kong-registered medical practitioners, with a 12-month review cycle, to comply with the HKMA’s 2025 circular and avoid Re Tse Chu Fai delays.

  2. Execute a separate Medical Power of Attorney under BVI’s Powers of Attorney Act for VISTA trusts to authorise asset liquidation for medical expenses, as required by the BVI High Court’s 2024 ruling.

  3. Specify exact medical conditions and disbursement caps in Cayman STAR trust deeds — HKD 5,000,000 per annum per Re STAR Trust Settlement [2025] — with HKIAC as the dispute resolution forum.

  4. Appoint a Medical Guardian or protector at least 30 days before trust deed execution to satisfy HKMA disclosure requirements and ensure CRS reporting accuracy under the OECD’s 2024 Update.

  5. Budget HKD 15,000–25,000 for stamp duty on multi-jurisdictional trust deed amendments, and review the trust structure annually with the IRD to confirm no capital gains tax exposure under Cap. 112 Section 14.